Defunct Company
Total Trials
3
As Lead Sponsor
1
As Collaborator
2
Total Enrollment
574
NCT00956280
Epidemiologic Study of KRAS Mutation in Brazilian Patients With Advanced or Metastatic Non Small Cell Lung Cancer
Phase: N/A
Role: Collaborator
Start: Sep 30, 2009
Completion: Apr 30, 2010
NCT01160796
Lcr35® for Bacterial Vaginosis Prevention
Phase: Phase 3
Role: Lead Sponsor
Start: Jun 30, 2010
Completion: Apr 30, 2012
NCT02502903
Safety, Tolerability and Activity of BIVV009 in Healthy Volunteers and Patients With Complement Mediated Disorders
Phase: Phase 1
Start: Jul 13, 2015
Completion: Mar 31, 2021